Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mainz Biomed NV MYNZ

Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.


NDAQ:MYNZ - Post by User

Post by BearDodger64on Nov 20, 2024 11:24am
23 Views
Post# 36321804

Mainz Biomed Takes Bold Step

Mainz Biomed Takes Bold Step
$MYNZ they might get extension period from Nasdaq mentioned on their latest statement
 
TipRanks
 
Nov. 15, 2024, 04:40 PM
Mainz Biomed B.V. (MYNZ) has released an update.
 
Mainz Biomed N.V. held an extraordinary general meeting where key proposals, including a reverse stock split, were approved. The reverse stock split aims to boost the company’s share price to comply with Nasdaq’s minimum bid requirements. This proactive measure seeks to secure Mainz Biomed’s continuous listing on the Nasdaq Stock Market.
<< Previous
Bullboard Posts
Next >>